Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-21-004387
Filing Date
2021-02-05
Accepted
2021-02-05 06:02:58
Documents
10
Period of Report
2021-02-05

Document Format Files

Seq Description Document Type Size
1 6-K tlc-6k_20210205.htm 6-K 18730
2 EX-99.1 tlc-ex991_6.htm EX-99.1 175491
3 GRAPHIC gbjxhvpbxj2g000001.jpg GRAPHIC 6244
4 GRAPHIC gbjxhvpbxj2g000006.jpg GRAPHIC 22373
5 GRAPHIC gbjxhvpbxj2g000004.jpg GRAPHIC 22373
6 GRAPHIC gbjxhvpbxj2g000008.jpg GRAPHIC 22373
7 GRAPHIC gbjxhvpbxj2g000003.jpg GRAPHIC 6244
8 GRAPHIC gbjxhvpbxj2g000005.jpg GRAPHIC 6244
9 GRAPHIC gbjxhvpbxj2g000002.jpg GRAPHIC 22373
10 GRAPHIC gbjxhvpbxj2g000007.jpg GRAPHIC 6244
  Complete submission text file 0001564590-21-004387.txt   354012
Mailing Address 2F, 3 YUANQU STREET NANGANG DISTRICT TAIPEI CITY F5 11503
Business Address 2F, 3 YUANQU STREET NANGANG DISTRICT TAIPEI CITY F5 11503 886 2 2655 7377
Taiwan Liposome Company, Ltd. (Filer) CIK: 0001722890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: F5 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38746 | Film No.: 21593303
SIC: 2834 Pharmaceutical Preparations